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The AAA ATPase, p97 achieves its versatility 
through binding to a wide range of cofactor 
proteins that adapt it to different cellular 
functions.  The heterodimer UN (comprising 
Ufd1 and Npl4) is an adaptor complex that 
recruits p97 for numerous tasks, many of which 
involve the ubiquitin pathway.  Insights into the 
structural specificity of p97 for its UN adaptor 
are currently negligible.  Here we present the 
solution structure of the Npl4 ‘ubiquitin-like’ 
domain (UBD), which adopts a ß-grasp fold 
with a 310 helical insert.  Moreover we 
performed a chemical shift perturbation 
analysis of its binding surface with p97N 
domain.  We assigned the backbone amides of 
p97 N domain and probed both its reciprocal 
binding surface with Npl4 UBD and its 
interaction with the p97-binding region of Ufd1.   
NMR data recorded on a 400 kDa full-length 
UN-hexamer p97 complex reveals an identical 
mode of interaction.   We calculated a 
structural model for the p97 N–Npl4 UBD 
complex and a comparison with the p97-p47 
adaptor complex reveals subtle differences in 
p97-adaptor recognition and specificity. 
 
 
The AAA ATPase p97 represents approximately 
1% of total cytosolic protein and is recruited by a 
myriad of adaptors to provide energy and/or 
mechanical force for wide-ranging cellular 
processes (for a recent review see (1)). p97’s 
homohexameric structure has now been solved in 
assorted permutations of nucleotide–bound states 
and biophysical methods including X-ray 
crystallography, electron microscopy and SAXS 
(2-6).  Each p97 monomer consists of three 
domains: N, D1 and D2.  Six  monomers associate 
together to form a homohexameric ring with a 
diameter of ~160 Å and central hole of ~20 Å.  
p97’s two ATPase domains, D1 and D2, and by 
association the N domain, move relative to each 
other as a result of ATP binding/hydrolysis events, 
affording the hexamer important mechanical 
properties (for review see (7).  In most cases the N 
domains form the sites of interaction between p97 
and some forty binding partners, which lend 
specificity to p97’s cellular actions via intricately 
woven protein signalling networks.   
The p97 adaptor complex comprising the 
heterodimer Npl4-Ufd1 (UN) (8) has biologically 
well-characterised roles in Endoplasmic 
Reticulum-Associated Degradation (ERAD) (9) 
and Regulated Ubiquitin-dependent Processing 
(RUP) (10,11) as well as other emerging functions 
including mitotic spindle disassembly (12).  Most, 
if not all, of these processes involve ubiquitin or 
its close relations.  ERAD is a quality-control 
process whereby incorrectly folded or obsolete 
proteins in the ER are retrotranslocated through 
channels in the ER membrane, polyubiquitinated 
and dismantled by the proteasome.  RUP employs 
the proteasome in more specific protein cleavage 
events, recognising monoubiquitin signals on 
membrane-bound transcription factors and 
severing them from the membrane thereby 
activating transcription.  
Despite extensive biochemical and 
genetics characterisation, structural information on 
the UN complex is only now coming together 
piecemeal.  Ufd1 is a 34.5 kDa protein that was 
discovered in a yeast screen for mutants that failed 
to degrade a model ubiquitinated substrate (13).  
The solution structure of Ufd1 residues 1-208 has 
been solved (14) and bears remarkable similarities 
to the p97 N domain structure (double psi-beta 
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barrel).  Ufd1 contains discrete binding sites for 
mono and tetraubiquitin on different surfaces of 
the molecule.  This has implications for the 
differential signalling roles of mono and 
tetraubiquitin in cellular processes.  There is 
currently no structural information for the C-
terminal portion of Ufd1 (residues 209-307) and, 
although it encompasses binding sites for both 
Npl4 (residues 258-275) and p97 (residues 215-
241) (15), it is unstructured when produced in 
isolation from these binding partners (Park et al., 
2005).  The only structural information currently 
available for Npl4 is an NMR solution structure of 
the 28 residue, zinc and ubiquitin-binding, NZF 
domain at its C-terminus (16).  Although, most of 
Npl4 has evaded structure determination, a 
ubiquitin-like domain (UBD) was identified by 
sequence alignment techniques, and shown to bind 
p97 N in pull-down assays (15).   
Results from biochemical data compared 
UN’s mode of binding to p97 with that of the other 
extensively characterised adaptor p47, which 
recruits p97 for homotypic membrane fusion 
events in a variety of different cellular processes 
(17).  UN and p47 compete for the same binding 
site on p97 N domain and, despite no sequence 
identity, appear to use very similar binding modes 
(15).  Both p47 and UN contain two binding sites 
for p97 N that permits a range of p97 
hexamer:adaptor stoichiometries between 1:1 and 
1:6. Cumulative evidence from electron 
microscopy, ITC, gel filtration and mass 
spectrometry experiments now ascertains that 
either three p47 molecules or one UN complex 
bind to the p97 hexamer (18,19). Here, we present 
a structural model for the Npl4 UBD in complex 
with the p97 N domain, the interface for the Ufd1-
p97 N interaction and discuss the implications for 
the UN-p97 hexamer complex. 
 
EXPERIMENTAL PROCEDURES 
 
Protein Expression - Npl4 UBD (residues 1-96) 
with a C-terminal His-tag was produced as 
described in (15).  p97 N domain (residues 1-213) 
with an N-terminal His tag was produced as 
described in (20). 15N-, 15N/13C-, and 2H/15N/13C-
labelled protein samples were prepared according 
to unlabelled protocols but in M9-based minimal 
media using correspondingly labelled ammonium 
chloride (>99% 15N), glucose (>99% U-13C), and 
deuterium oxide (>99.9% 2H).  The UN complex 
and a fragment of murine p97 encompassing the 
N-terminal and D1 ATPase domains (p97 ND1) 
were produced as previously described (2,8,21).  
Uniformly deuterated samples of Npl4 or Ufd1 
were prepared by expression in the appropriate 
Spectra9 media (Spectra Gases Ltd).   
NMR Spectroscopy and Structure Calculation for 
Npl4 UBD - Backbone and side-chain assignment 
were completed using standard double and triple-
resonance assignment methodology (22). Hα and 
Hβ assignments were obtained using 
HBHA(CBCACO)NH (22).  The side-chain 
assignments were completed using HCCH-total 
correlation (TOCSY) spectroscopy and 
(H)CC(CO)NH  TOCSY (22).  3D 1H-15N/13C 
NOESY-HSQC (mixing time 100 ms at 500 MHz 
and 800 MHz) experiments provided the distance 
restraints used in the final structure calculation.  
 A total of 42 long-range NOEs, providing 
unambiguous 3D characterisation of the fold for 
Npl4 UBD, were manually assigned from the 
NOESY data.  The ARIA protocol (23) was used 
for augmentation of the NOE assignment and final 
structure calculation.  Using the initial model as 
the starting structure in the first iteration a total of 
750 NOE-derived distances were assigned from 
13C- and 15N-edited spectra.  Dihedral angle 
restraints derived from TALOS were also 
implemented (24).  The frequency window 
tolerance for assigning NOEs was ± 0.05 ppm and 
±0.07 ppm for direct and indirect proton 
dimensions and ± 0.7 ppm and ± 1.2 ppm for 
nitrogen and carbon dimensions, respectively.  The 
ARIA parameters were set to default values with 
the exception of the violation tolerances which 
were set to 1.0, 1.0, 0.5, 0.2, 0.1, 0.3, 0.1, 0.0 and 
0.0 Å in the 9 iterations. 
NMR Titrations - Samples of either p97 N, Npl4 
UBD, UN or Ufd1 peptide were concentrated to 50 
µM in 25 mM HEPES buffer, pH 7.5, and 125 
mM NaCl.  Spectra were recorded in the absence 
and presence of the binding partner in appropriate 
molar ratios.  For the p97 N-Npl4 UBD interaction 
molar ratio were 1:0.2, 1:0.5, 1:0.75, 1:1.3, 1:2, 
1:2.4, 1:2.8, 1:3.9 and 1:6.  All resolved shift 
changes were monitored by 2D 1H-15N HSQC 
spectra and fitted to a single binding site saturation 
isotherm within Excel (Microsoft Corporation).  
For the other titrations the following molar ratio 
were used; p97 N:Ufd1 pep— 1:1, 1:20, 1:50, 
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1:100; ufd1 pep + p97 N—1:0.5, 1:1, 1:2 and 1:5; 
UN + p97 ND1—1:0.5, 1:1 and 1:1.5;  
Structure Calculation for Npl4 UBD-p97 N 
complex - The chemical shift perturbation studies 
delineated clear interaction surface areas in the 
p97 N-Npl4 UBD complex making this highly 
suitable for structure calculation using the 
HADDOCK approach (25).  For the calculation, 
the crystal structure of p97 N and the lowest 
energy NMR structure from the family of Npl4 
UBD structures were used.  32 amino acid residues 
in Npl4 UBD and 58 in p97 N were identified to 
have weighted chemical shift changes significantly 
greater than the average; 0.253 ppm in Npl4 UBD 
and 0.186 ppm in p97 N were chosen as suitable 
cut-off values.  After filtering for a relative solvent 
accessibility greater than 50%, as calculated using 
the program Naccess (26), twelve residues in Npl4 
UBD (4, 8, 16, 17, 21, 50, 51, 69, 70, 71, 74, 77) 
and sixteen for p97 N (50, 52, 54, 107, 109, 110, 
112, 113, 133, 140, 141, 142, 156, 166, 171, 179) 
were identified as active residues.  Residues 
juxtaposed to these that have a relative solvent 
accessibility greater than 50% were termed passive 
residues.  These included eleven further residues 
in Npl4 UBD (2, 3, 12, 14, 15, 23, 39, 52, 53, 68, 
72) and sixteen in p97 N (23, 43, 47, 48, 53, 106, 
126, 131, 155, 157, 158, 169, 178, 181, 182, 191).  
An ambiguous distance restraint of 3.0 Å was 
invoked between all active residues in one partner 
molecule to any atom within the active and passive 
residues of the other protein partner.   The 
interfacial residues that were allowed to move 
during the simulated annealing and water 
refinement were residues 12-21 and 31-43 for 
Npl4 UBD and 44-52 and 65-76 for p97 N. One 
thousand initial complex structures were generated 
by rigid body energy minimisation and the best 
two hundred by total energy were selected for 
torsion angle dynamics and subsequent Cartesian 
dynamics in an explicit water solvent.  Default 
scaling for energy terms was applied as described 
previously (25).   
 
RESULTS 
 
Npl4 has, thus far, evaded structure 
determination largely because of its intrinsic 
flexibility and instability in the absence of Ufd1 
(NMR data not shown).  Figure 1 shows a 1H-15N 
HSQC spectrum of the entire 100 kDa UN 
complex in which Npl4 is isotopically 15N 
labelled.  Only peaks corresponding to the UBD 
and NZF domains have favourable relaxation 
properties and are therefore visible in HSQC 
spectra, indicating that these domains, at the N and 
C termini of Npl4, exhibit some degree of 
independence.  The chemical shifts for amides 
from these domains are unchanged when 
compared to the individual fragments suggesting 
their structures are identical. 
 The predicted ubiquitin-like domain 
(UBD) of Npl4, comprising residues 1-96 of the 
full-length protein, was produced recombinantly 
with isotopic labelling in E. coli. Although the 
battery of NMR spectra obtained from this protein 
typified a compact folded domain, a significant 
number of backbone amide resonances were broad 
or missing from the data.  Varying pH, buffer and 
temperature conditions failed to recover the absent 
peaks.  Following backbone assignment (Figure 
1A) it became clear that these data corresponded 
to a contiguous stretch of the protein sequence 
(residues 60-68) implying a potentially interesting 
region exhibiting intermediate conformational 
exchange.  Furthermore, residues 80-96 were 
completely unstructured based on their amide 
relaxation properties (data not shown), comparison 
to random coil chemical shifts and the absence of 
inter-residue NOEs in NOESY spectra.  Although 
NOE data were not available for these regions, it 
was possible to calculate a solution structure for 
the majority of the domain (Figure 2 and Table I).  
The secondary structure occupies a core ββαβαβ 
topology and manual assignment of key NOEs 
revealed a β-grasp-like fold with similarities to 
ubiquitin.  An initial β-grasp fold model for Npl4 
UBD was used as a starting structure in an 
automatic NOE assignment using the ARIA 
protocol (23).  All areas of identified secondary 
structure are well defined (Figure 2A); the average 
pair-wise root mean squared deviation (RMSD) 
for the water-refined final family of structures is 
0.88 Å for the backbone atoms of secondary 
structure elements. The experimentally determined 
secondary structure of Npl4 UBD consists of two 
helices (α1 between Ala 26 – Phe 37 and a 310 (α2) 
between Arg 50 – Glu 55), and four β-strands (β1: 
Ile 5 – Gln 10; β2: Val 15 – Ala 20; β3: Tyr 47 – 
Ile 48; β4: Leu 74 - Phe 76) assembled in a β-
grasp-like fold (Figure 2B).  The β-strands form a 
mixed sheet in a 2-1-4-3 arrangement where 2-1 
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and 4-3 adopt anti-parallel pairing and 1 and 4 are 
parallel to each other.  Figures 2C and 2D show 
superimposition of Npl4 UBD with structures 
identified as having the most similar topology: 
ubiquitin (11 % identity and RMSD 2.7 Å over 56 
residues) and the β-grasp protein from Arabidopsis 
thaliana (PDB accession code: 1WF9; 20 % 
identity and RMSD 2.7 Å over 61 residues), 
respectively. These structural homologues provide 
hints as to the structure of the missing region from 
Npl4 UBD.  In all UBD structures solved to date 
this region corresponds to a long loop region 
containing a short α–helix. Figure 2E shows a 
structure-based sequence alignment of Npl4 UBD, 
ubiquitin, p47 UBX and the β-grasp protein from 
Arabidopsis (1WF9) with conserved residues 
highlighted.   
Reciprocal chemical shift perturbation 
studies were performed to map the interaction 
surface between Npl4 UBD domain and the N 
domain of p97.  Figure 3A shows a comparison of 
the 1H-15N heteronuclear single-quantum 
coherence (HSQC) spectra of uniformly 15N-
labelled Npl4 UBD in the presence and absence of 
p97 N.  Twenty-two significantly perturbed 
residues were observed, while most of the 
spectrum remained unchanged, indicating the 
formation of a specific complex between the two 
proteins. Figure 3A highlights some of the more 
prominent shifts and includes multiple increments 
from the titration demonstrating that binding is 
within the fast-exchange limits of the NMR 
timescale. Changes in chemical shift measured 
with increasing peptide concentration were fitted 
to a standard single binding-site saturation 
isotherm yielding an estimated Kd in the range of 
10-100 µM.   Mapping the perturbed residues onto 
the structure of Npl4 UBD delineated the binding 
surface, which spans the exposed face of the β-
sheet and neighbouring loop regions with key 
shifted residues congregating on β1 and β3 (Figure 
3B).  
The structure of p97 N domain is known 
from X-ray crystallographic studies on the larger 
p97 ND1 construct (2).  Using a standard triple 
resonance NMR approach, we assigned the 
backbone amide resonances of the 24 kDa 
fragment, and identified which residues participate 
in binding to the UBD domain of Npl4.  1H-15N 
HSQC spectra of uniformly 15N-labelled p97 were 
recorded in the presence and absence of Npl4 
UBD (Figure 4C).  In this case 35 out of a possible 
213 residues were significantly perturbed and the 
binding surface maps to the negatively-charged 
groove between the two sub-domains of p97 N, 
(Nn and Nc) (Figure 4B).  Prominent sites of 
interaction occur in the loops between β1 and β3, 
β7 and β8, β12 and β13 and the long loop between 
β6 and β7 that connects the Nn and Nc sub-
domains of p97 N.   
The clear delineation of a binding 
interface using chemical shift mapping has 
enabled us to adopt an NMR restraint-guided 
docking approach (HADDOCK) (25) to generate a 
structural model for the complex. The 
stoichiometry of the UN-full-length p97 has been 
previously established by electron microscopy,  
mass spectrometry and gel filtration in which one 
UN heterodimer binds one p97 hexamer (18), thus 
inferring a 1:1 stoichiometry for the p97 N:UBD 
interaction.  Furthermore, chemical shift 
movements fit well to a single binding site 
isotherm. Standard ambiguous interaction 
restraints (AIRs) between Npl4 UBD and p97 N, 
based on residues experiencing greater than 
average NMR chemical shift perturbations , were 
used to drive the calculation (see Materials and 
Methods).  The 200 final refined structures for the 
p97 N-Npl4 UBD complex were clustered 
according to a pair-wise RMSD cut-off of 2.5 Å, 
producing two major clusters of 14 and 18 
structures.  The average intermolecular energy for 
the best cluster was -555 ± 55 kcal mol-1.  Figure 
5A shows an overlay of the 10 lowest interactional 
energy, water-refined structures from the low 
energy cluster. As suggested by the chemical shift 
mapping data, the model shows the Npl4 UBD 
binding within the groove formed between the two 
sub-domains of p97 N, in an analogous fashion to 
p47 UBX domain binding (Figures 5B and 5C). 
This interface differs from p47 in that the S3-S4 
region in Npl4 UBD is elaborated with a 310 helix 
(Figure 5D) that provides specific contacts to p97 
N. Also highlighted in Figure 5D are three critical 
residues in Npl4 UBD that project into the 
hydrophobic binding pocket with p97 N: Val 15, 
Leu 74 and Phe 76 (which contact Lys 109, Gly 54 
and Tyr 143 in p97 N, respectively). In alignment 
with p47 these amino acids equate to Arg 307, Val 
366 and Arg 368, all of which make the 
corresponding p97 contacts and are seen to shift in 
the earlier NMR study.  
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To assess whether our structural model for 
Npl4 UBD-p97 N represents the likely mode of 
interaction within the UN heterodimer-p97 
hexamer complex, we performed a TROSY and 
CRINEPT-based NMR titration of 300 kDa 
hexameric p97 ND1 into full-length 100 kDa UN, 
in which Npl4 is uniformly 2H,15N-labelled and 
Ufd1 is unlabelled.  Interestingly, the 2H-15N 
TROSY spectrum of free UN revealed a 40-50 
kDa structured core domain within Npl4, in 
addition to the terminal UBD and ZF domains, 
which folds upon interaction with Ufd1 (Figure 3A 
- right).  In CRINEPT and TROSY spectra of the 
1:1 UN:p97 ND1 hexamer complex a number of 
UBD resonances disappear whilst the rest of the 
spectrum remains largely unchanged (Figure 3A - 
right). These peaks correspond exactly to the 
UBD-p97 N interface identified in our chemical 
shift mapping experiments and their absence is 
probably due to the faster relaxation properties 
exhibited when bound to the protonated 300 kDa 
p97 hexamer.  The observation of peaks from the 
core domain and ZF in the TROSY spectrum of 
this 400 kDa complex suggests they exhibit a 
degree of independence from the hexameric unit.  
The portion of Ufd1 that binds to p97 N 
has been localised to a region spanning residues 
215-241 (15).  This sequence displays some 
limited identity with a stretch of amino acids in 
p47, known to bind p97 N, which occurs in the 
linker region between the p47 UBX and SEP 
domains. To localise further the interacting region 
within Ufd1 we synthesised a specifically labelled 
peptide in which a selection of 15N/13C labelled 
amino acids were incorporated throughout the 
sequence (i.e. labels in bold and underlined 
DHSGYAGEVGFRAFSGSGNRLDGKKKG).  
1H-15N and 1H-13C HSQC spectra of the peptide 
were recorded in the presence of increasing 
amounts of p97 N.  G224, A227 and G230 
resonances were severely broadened upon 
interaction with p97 N (Figure 6A), while the 
remaining resonances were unaffected.  The 
residues displaying broadened NMR signals 
delineate the p97 N-binding site and line 
broadening is likely caused by the peptide 
exhibiting conformational exchange on the ms-µs 
timescale within the complex. Building on our 
previous experiments we also titrated an 
unlabelled peptide into 15N-labelled p97 N to 
observe its binding interface.  Figure 4C shows the 
HSQC spectra of uniformly 15N-labelled p97 N in 
the presence and absence of Ufd1 peptide. 
Surprisingly, we discovered that some of the 24 
p97 N residues perturbed upon Ufd1 peptide 
addition fall within the binding interface between 
p97 N and Npl4 UBD (Figures 4A and 4B), 
implying that a degree of communication may 
exist in binding these two motifs.  We also 
performed a competition experiment in which p97 
N was saturated with Ufd1 peptide and then 
titrated with increasing amounts of Npl4 UBD.  
All chemical shift movements caused by the Ufd1 
peptides are reversed after a saturating titre of 
Npl4 UBD has been added (Figure 4C).   
 
DISCUSSION 
 
Together Npl4 and Ufd1 recruit p97 to 
specific ubiquitin-related cellular processes. We 
provide the first structural characterisation of this 
interaction at a molecular level. Npl4 and Ufd1 
each contain a region that contacts p97 N and 
these sites resemble functionally the two regions in 
p47, another p97 adaptor protein. The Npl4 
binding site for p97 N occurs in the N-terminal 
UBD domain, which exhibits a novel β-grasp-like 
fold.  
Using chemical shift perturbation studies 
we delineated the region on Npl4 UBD that binds 
to p97 N. This surface is reminiscent of the I44 
face hydrophobic patch on ubiquitin that 
represents the binding site for many of its cohorts.  
Interestingly, the region of Npl4 UBD that is in 
severe intermediate conformational exchange  
(residues 60-68)  lies outside the p97 binding 
surface identified by the HADDOCK calculation, 
implying that the missing data are not a 
consequence of the p97 N binding site.  
Furthermore, resonances from this region remain 
conformationally broadened even in the presence 
of saturating amounts of p97 N. This area might 
represent a site of association with part of Ufd1 or 
another region from full-length Npl4 since the 
UBD represents approximately one sixth of the 
whole protein. This is consistent with NMR 
observations suggesting that the UBD domain is 
not tumbling entirely independently from the main 
body of the UN complex.   
We identified the reciprocal UBD-binding 
surface on p97 N domain, which is located in the 
cleft between the Nn and Nc sub-domains. 
 6
Strikingly, this Npl4 UBD binding area 
encompasses the p97 N domain amino acids (R93, 
R95 and R155) found missense-mutated in 
hereditary Inclusion Body Myopathy with Paget 
disease of bone and Frontotemporal Dementia 
(IBMPFD) (27).  R93 is a shifted residue in our 
NMR titration experiments with UN and p97 N, 
and R155 is directly adjacent to a shifted residue.  
Weihl et al. have shown that p97 bearing the most 
common IBMPFD mutation, R155H, retains its 
usual hexameric structure and ATPase activity yet 
exhibits impaired ERAD function (27). Our 
findings suggest that this is probably a result of 
inhibited or modified binding to the UN complex. 
Yuan et al. mapped the p97 N binding 
surface on p47 in a chemical shift perturbation 
study yielding data directly comparable with ours 
(28). Dreveny et al. expanded this information by 
solving a crystal structure of the complex between 
p47 and p97 and illustrated the importance of the 
S3-S4 loop within p47 as a key point of interaction 
with the cleft of p97 N (20). They showed that the 
analogous loop from ubiquitin did not provide the 
necessary contacts for high affinity binding. 
The information we gained from mapping 
both binding surfaces allowed us to generate a 
model for the complex of Npl4 UBD and p97 N.  
We also demonstrate using NMR that this mode of 
interaction exists in the full length UN in complex 
with hexameric p97. Our model also reveals 
striking similarities to the crystal complex of p47 
with p97 N, with the key p97 N-interacting 
residues in Npl4 UBD aligning structurally with 
the corresponding residues in p47. Although Npl4 
UBD resembles ubiquitin rather than p47 in the 
length of its S3-S4 loop and overall structure, 
mutagenesis data confirm the importance of this 
region (15).  Figure 5E illustrates the key locations 
of these mutated residues within the protein-
protein interface of the UBD-p97 N complex. Our 
model reveals that although these residues play a 
role in the interface they lie proximal to the main 
region of interaction.  The S3-S4 region in Npl4 is 
decorated with a 310 helix distinguishing it from 
both p47 (and ubiquitin) and suggesting a 
mechanism for specificity between the two p97 
adaptors. 
Despite dramatic variations in sequence, 
many of the known p97 adaptor proteins, 
including p37, p47, Ubx2, VCIP135, Faf1 and 
Saks1 bind to the N domain via ubiquitin-like 
motifs (29-32).  There are likely to be substantial 
parallels between the binding modes of these 
domains to p97 N. Comparing the published p47 
data with the UN data presented here we can 
speculate that these ubiquitin-like domains 
recognise the p97 N cleft using similar, yet subtly 
different, interaction modes. EM and 
stoichiometric studies by Pye et al. assign these to 
macroscopic differences in organisation since, 
despite our discovery of analogous residue 
interactions at the binding interface, a p47 trimer 
appears to straddle the p97 hexamer while a single 
UN complex projects from one side (18).   
Upon examining the interaction between 
Ufd1 and p97 N, our NMR data suggest that the 
The p97 N-binding region in Ufd1 can be localised 
to a short region encompassing G224, A227 and 
G230.  The phenylalanine, alanine and glycine 
residues within this stretch are highly conserved 
(Figure 6B) and expected to make key interactions 
with p97 N. Surprisingly, chemical shift 
perturbations induced in p97 N spectra in the 
presence of Ufd1 are reversed upon the addition 
the UBD.  While it may be difficult to extrapolate 
data on a small peptide motif to the native system, 
it suggests a degree of communication between the 
Npl4 and Ufd1 binding sites on p97. Although low 
resolution EM data indicate that the UN complex 
associates with one N domain of p97, as the 
authors suggest, this may represent a snapshot in a 
process of mechanical rearrangements associated 
with UN binding to the p97 hexamer during 
activity (18).  Bearing in mind the inherent 
flexibility of the UN complex and potential 
interplay between the Ufd1 and Npl4 binding sites, 
it is also plausible that the UN complex spans two 
adjacent N domains.  
Bruderer et al. drew biochemical parallels 
between p47 binding to p97 N via two interaction 
points (in its UBX domain and in the linker to 
SEP) and UN binding through the structurally 
analogous regions in Npl4 UBD and Ufd1 peptide 
(15). Evidence implies that the p47 bipartite 
binding site can span two N domains, as p47 binds 
p97 as a trimer presenting two adjacent N domains 
per p47 molecule (19,20).  The bipartite motif is 
also conserved in p37 a novel adaptor of p97 that 
is required for Golgi and ER biogenesis (33). The 
subtle differences presented in the UBD-p97 N 
interaction and the stark difference in their 
connectivities to the second binding site, i.e. 
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covalently in the case of p47/p37 and non-
covalently in UN, provide scope for varied modes 
of p97-mediated adaptor binding and activity. 
It is conceivable that conformational 
changes in p97 N, induced by nucleotide 
binding/hydrolysis or UN-binding, could facilitate 
a mechanism for the bipartite binding motif to 
alter their arrangement within the p97 hexamer 
and propagate signals to the substrate. 
Furthermore, alterations in N domain accessibility 
may prime them to receive new co-adaptors, for 
example Ufd2 or Ufd3.   
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FIGURE CAPTIONS 
 
FIGURE 1.  Assigned 1H-15N HSQC NMR spectrum of the Npl4 UBD domain (A). Inset 
shows the 1H-15N HSQC of 15N-labelled Npl4 in the context of UN, with UBD 
domain peaks shown in magenta and NZF peaks in black. Assigned 1H-15N HSQC 
NMR spectrum of p97 N (B) Inset shows an expanded region of the central portion 
of the p97 N spectrum. 
 
FIGURE 2. Solution structure of Npl4 UBD domain. (A) Cα traces representing the 
superimposition of the 10 refined Npl4 UBD domain structures. (B) Ribbon 
representation of Npl4 UBD domain for the orientation displayed in (A). (C) 
Superposition of Npl4 UBD domain (pink) with ubiquitin (green) (PDB accession 
number 1UBQ) (34) (D) Superposition of Npl4 UBD domain (pink) with β grasp 
protein (cyan) from Arabidopsis thaliana (PDB accession number 1WF9) (E) 
Structure-based sequence alignment of Npl4 UBD domain (residues 1-80), 
ubiquitin (residues 1-76), p47 UBX domain (residues 292-371) and β grasp protein 
(residues 1-91) from Arabidopsis thaliana (Swiss PDB accession number 1WF9). 
 
FIGURE 3.   Identification of the interaction surfaces on Npl4 UBD domain for p97 N.  (A) 
1H-15N HSQC spectra of the Npl4 UBD domain with increasing amounts of p97 N 
(left) and  1H-15N TROSY spectra of 2H/15N labelled Npl4 UN in the absence and 
presence of hexameric p97 ND1 (right, *  and † indicate resonances from the core 
domain and ZF, respectively) .  (B) Surface and ribbon representations of Npl4 
UBD domain with residues coloured white to red in ten shaded increments of 
increasing normalised 1H/15N chemical shift perturbations observed the presence 
of p97 N. Residues greater than 80% of maximum chemical shift are coloured 
darkest red. Between 0 and 80% is divided equally across the 9 remaining colours.  
The maximum combined chemical shift is 1.79 ppm. 
FIGURE 4.  p97 N interaction surfaces for Npl4 UBD domain and Ufd1 peptide overlap.  
(A) Surface and ribbon representations of p97 ND1 with residues coloured white to 
red in ten shaded increments of increasing normalised 1H/15N chemical shift 
perturbations observed the presence of Ufd1 peptide. Residues greater than 80% 
of maximum chemical shift are coloured darkest red. Between 0 and 80% is 
divided equally across the 9 remaining colours.  The maximum combined chemical 
shift is 2.05 ppm.. The orientation of the smaller surface representation is 180o 
rotation of that shown for the large surface and ribbon representations.  The 
coordinates for the p97 N structure are taken from PDB accession number 1E32 
(2) (B) Surface and ribbon representations of p97 ND1 with residues coloured 
white to red in ten shaded increments of increasing normalised 1H/15N chemical 
shift perturbations observed the presence of Npl4 UBD.  The orientation of the 
smaller surface representation is 180o rotation of that shown for the large surface 
and ribbon representations   Residues greater than 80% of maximum chemical 
shift are coloured darkest red. Between 0 and 80% is divided equally across the 9 
remaining colours.  The maximum combined chemical shift is 2.42 ppm.  The 
coordinates for the p97 N structure are taken from PDB accession number 1E32 
(2) (C) Comparison of 1H-15N HSQC spectra for the p97 N domain in the absence 
(magenta) and presence (blue) of Ufd1 peptide, and after the subsequent addition 
of excess Npl4 UBD (green).  Arrows indicate key chemical shift perturbations 
upon the addition of Ufd1 peptide (left spectrum) and Npl4 UBD (right spectrum) 
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FIGURE 5. HADDOCK-derived model for the Npl4 UBD – p97 N complex. (A) Cα traces 
representing the superposition of the 10 refined Npl4 UBD-p97 N complex 
structures using the HADDOCK approach. (B) Ribbon representation of the Npl4 
UBD (pink) – p97 N (blue) complex (C) Ribbon representation of the p47 UBX 
(gold) - p97 N (blue) complex. The coordinates for the p47 UBX-p97 N complex 
are taken from PDB accession number 1S3S (20) (D) Close-up view of key 
interacting side-chains shown in stick representation. (E) Close-up view of residues 
in Npl4 UBD which, when mutated by Bruderer et al. (2004), abolished binding to 
p97 N domain 
FIGURE 6.  Localisation of the p97 N interaction motif within Ufd1. (A) 1H-13C HSQC 
spectra of the specifically labelled Ufd1(215-241) peptide 
(DHSGYAGEVGFRAFSGSGNRL DGKKKG, 13C/15N labels in bold and underlined) 
within increasing amounts of p97 N.  (B) Sequence alignment of the Ufd1 peptide 
with p47 homologues illustrating the conserved nature of this motif.  
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Table 1  Structural statistics for Npl4 UBD domain solution structure calculation 
 
 
 
 
 
 
 
 
 
Solution Structure 
 Npl4 UBD (pdb: 1abc) 
Number of experimental restraints 716 
Total NOE-derived 630 
Ambiguous 119 
Unambiguous 511 
Talos (φ/ψ) 86 
RMSD from experimental restraints  
Distance (Å) 0.05 ± 0.005 
Dihedral angle (deg.) 0.9 ± 0.1 
RMSD from idealized covalent geometry  
Bonds (Å) 0.0041 ± 0.0002 
Angles (deg.) 0.56 ± 0.02 
Coordinate RMSD (Å)  
Backbone atoms in secondary structure 0.88 ± 0.16 
Heavy atoms in secondary structurea 1.52 ± 0.15 
Ramachandran plot   
Residues in most favoured regions (%)  73 
Residues in allowed regions (%)  22 
Residues in disallowed regions (%)   5 
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Ufd1 DHSGYAGEVGFRAFSGSGNRLDGKKKG
F+AF+G G  L   
p47hs DEDFVKPKGAFKAFTGEGQKLGSTAPQ
P47zf DEDFVKPKGAFKAFTGEGQKLGSATPE 
P37mm DQEYIKPRLRFKAFSGEGQKLGSLTPE
